Detalhe da pesquisa
1.
Remission induction versus immediate allogeneic haematopoietic stem cell transplantation for patients with relapsed or poor responsive acute myeloid leukaemia (ASAP): a randomised, open-label, phase 3, non-inferiority trial.
Lancet Haematol;
11(5): e324-e335, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38583455
2.
Donor KIR genotype based outcome prediction after allogeneic stem cell transplantation: no land in sight.
Front Immunol;
15: 1350470, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38629074
3.
Acalabrutinib, venetoclax and obinutuzumab in relapsed CLL: Final efficacy and ctDNA analysis of the CLL2-BAAG trial.
Blood;
2024 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38620072
4.
Mimicking clinical trials with synthetic acute myeloid leukemia patients using generative artificial intelligence.
NPJ Digit Med;
7(1): 76, 2024 Mar 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-38509224
5.
Allogeneic hematopoietic stem-cell transplantation for patients with Richter transformation: a retrospective study on behalf of the Chronic Malignancies Working Party of the EBMT.
Bone Marrow Transplant;
2024 Mar 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-38503942
6.
Providing hematopoietic stem cell products from unrelated donors to the world: DKMS donor centers and DKMS Registry.
Best Pract Res Clin Haematol;
37(1): 101541, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38490766
7.
Improvements in Posttransplant Outcomes Over Two Decades in Older Patients with Acute Myeloid Leukemia in the EBMT ALWP Study.
Clin Cancer Res;
30(9): 1778-1787, 2024 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38514469
8.
Harmonizing definitions for hematopoietic recovery, graft rejection, graft failure, poor graft function, and donor chimerism in allogeneic hematopoietic cell transplantation: a report on behalf of the EBMT, ASTCT, CIBMTR, and APBMT.
Bone Marrow Transplant;
2024 Mar 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-38443706
9.
Smart Conditioning with Venetoclax-Enhanced Sequential FLAMSA + RIC in Patients with High-Risk Myeloid Malignancies.
Cancers (Basel);
16(3)2024 Jan 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-38339283
10.
Six-year follow-up and subgroup analyses of a phase 2 trial of venetoclax for del(17p) chronic lymphocytic leukemia.
Blood Adv;
8(8): 1992-2004, 2024 Apr 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-38290108
11.
Systematic evaluation of donor-KIR/recipient-HLA interactions in HLA-matched hematopoietic cell transplantation for AML.
Blood Adv;
8(3): 581-590, 2024 02 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-38052043
12.
Tislelizumab plus zanubrutinib for Richter transformation: the phase 2 RT1 trial.
Nat Med;
30(1): 240-248, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-38071379
13.
Allogeneic hematopoietic stem cell transplantation in patients aged 60-79 years in Germany (1998-2018): a registry study.
Haematologica;
109(2): 431-443, 2024 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37646665
14.
Haplotype reconstruction for genetically complex regions with ambiguous genotype calls: Illustration by the KIR gene region.
Genet Epidemiol;
48(1): 3-26, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-37830494
15.
Dissolution of spiral wave's core using cardiac optogenetics.
PLoS Comput Biol;
19(12): e1011660, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-38060618
16.
Immune Surveillance of Acute Myeloid Leukemia Is Mediated by HLA-Presented Antigens on Leukemia Progenitor Cells.
Blood Cancer Discov;
4(6): 468-489, 2023 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37847741
17.
Mutated IKZF1 is an independent marker of adverse risk in acute myeloid leukemia.
Leukemia;
37(12): 2395-2403, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37833543
18.
Anti-CD3/CD7 immunoconjugate (T-Guard) for severe, steroid-refractory GVHD: final report of BMT CTN 2002.
Bone Marrow Transplant;
58(12): 1416-1418, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37749187
19.
Secondary-type mutations do not impact outcome in NPM1-mutated acute myeloid leukemia - implications for the European LeukemiaNet risk classification.
Leukemia;
37(11): 2282-2285, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37679502
20.
The role of anti-thymocyte globulin in allogeneic stem cell transplantation (HSCT) from HLA-matched unrelated donors (MUD) for secondary AML in remission: a study from the ALWP /EBMT.
Bone Marrow Transplant;
58(12): 1339-1347, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37660157